24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Do Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in California'Ultra-Processed' Foods Up Odds for a Second Heart Attack or StrokeCDC to Toughen COVID Testing for International TravelersAHA News: Irregular Heartbeat Risk Linked to Frequent Alcohol Use in People Under 40Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERRed Light in Morning May Protect Fading Eyesight: StudyMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'Gout Drug Colchicine Won't Help Fight COVID-19What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyCOVID Protection Wanes After 2 Doses of Pfizer Vaccine: StudyRural Hospitals' ERs Just as Effective as Urban Ones: Study1 in 5 Avoided Health Care During Pandemic, Study FindsBoosters: What You Need to KnowAHA News: Pulmonary Embolism Is Common and Can Be Deadly, But Few Know the SignsAlmost 1 in Every 3 College-Age Americans Are Now ObeseAnimal Study Offers Hope for a Vaccine Against Lyme DiseaseAddictive Opioid Painkillers Might Not Be Needed After Knee SurgeryYears of Blood Thinners After Stenting Might Not Be NecessaryU.S. COVID Cases, Hospitalizations on the Rise Just Before ThanksgivingVaping Could Weaken Your Bones, Study FindsWearable Vibration Device May Ease Parkinson's TremorPfizer Says Its COVID Vaccine Provides Full Protection to AdolescentsBooster Shots Prompt Stronger, Longer Protection Than Original Shots: StudyTV Remotes, Nurse Call Buttons: Where Coronavirus Lingers in Nursing Homes
Questions and AnswersLinks
Related Topics

Diabetes

Clot-Busting Drugs Safe in Stroke Patients When Brain Aneurysm Hasn't Ruptured

HealthDay News
by Robert Preidt
Updated: Oct 12th 2021

new article illustration

TUESDAY, Oct. 12, 2021 (HealthDay News) -- Clot-busting drugs may be safe for certain stroke patients with brain aneurysms that haven't ruptured, researchers say.

An aneurysm is a bulge in the wall of a blood vessel. In the new study, patients had suffered an ischemic stroke, which is caused by blocked blood flow in the brain.

Even though clot-busting drugs are the main treatment for ischemic stroke, they're often not given to people who have an aneurysm in their brains that has not ruptured.

But this study found that brain aneurysms rarely rupture after treatment with clot-busting drugs.

The researchers analyzed data on all stroke patients who received clot-busting drugs at a stroke center in Finland over 15 years.

Of the nearly 4,000 patients, 132 had one or more unruptured aneurysms. Of the 155 unruptured aneurysms, 141 were saccular aneurysms, the most common type of brain aneurysm, and 14 were fusiform aneurysms.

Aneurysm ruptures that resulted in bleeding strokes occurred in only three (2.3%) of those 132 patients. All three had large, spindle-shaped aneurysms called fusiform basilar artery aneurysms, and all three were treated with blood thinners after receiving clot-busting drugs. None of the saccular type of aneurysms, which are often shaped like berries, ruptured.

The study was published online Oct. 6 in the journal Neurology.

"These results are exciting because they may expand the population who can receive these thrombolytic [clot-busting] therapies that can prevent death and disability for people with strokes," study author Dr. Jyri Juhani Virta, from the University of Helsinki in Finland, said in a journal news release.

"Fortunately, today blood thinners are not commonly used early after ischemic stroke, so that may help to reduce this risk even further," Virta said. "Our results suggest that thrombolytic therapy may be relatively safe for people with ischemic stroke even if they have larger saccular aneurysms that have not ruptured. For people with large fusiform aneurysms, additional consideration should be taken regarding treatment as blood thinners may increase the risk of aneurysm rupture."

A limitation of the study was that only a small number of people had large aneurysms.

More information

The American Stroke Association has more on types of stroke and treatment.

SOURCE: Neurology, news release, Oct. 6, 2021